Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
Related Research units
Abstract
Treosulfan was introduced recently as a conditioning agent for allogeneic blood stem-cell transplantation. The favorable nonhematologic toxicity profile at 3 x 10 g/m(2) was the basis for dose escalation in this prospective, multicenter trial.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 20 |
| ISSN | 0732-183X |
| Publication status | Published - 2010 |
| pubmed | 20498405 |
|---|
